Knowledge Hubs
Bladder Cancer Knowledge Hub
PSMA Knowledge Hub
Phenotypic Precision Medicine in Advanced Prostate Cancer
Conferences
2022
SNMMI 2022 Annual Meeting
2022 American Society Of Clinical Oncology Annual Meeting
AUA 2022
American Society Of Clinical Oncology GU Symposium 2022
2021
The Society of Urologic Oncology 22nd Annual Meeting
American Society of Clinical Oncology Annual Meeting 2021
AUA 2021
Videos
Latest Videos
Round the Wire
American Society Of Clinical Oncology GU 2022: Key Takeaways in Prostate Cancer Imaging
PSMA Imaging and More
The Uromigos
Journal
2022
2021
Search
Docwire News
Knowledge Hubs
Bladder Cancer Knowledge Hub
PSMA Knowledge Hub
Phenotypic Precision Medicine in Advanced Prostate Cancer
Conferences
2022
SNMMI 2022 Annual Meeting
2022 American Society Of Clinical Oncology Annual Meeting
AUA 2022
American Society Of Clinical Oncology GU Symposium 2022
2021
The Society of Urologic Oncology 22nd Annual Meeting
American Society of Clinical Oncology Annual Meeting 2021
AUA 2021
Videos
Latest Videos
Round the Wire
American Society Of Clinical Oncology GU 2022: Key Takeaways in Prostate Cancer Imaging
PSMA Imaging and More
The Uromigos
Journal
2022
2021
Home
GU Oncology Now Picks
ASCO GU Symposium 2022
ASCO GU Symposium 2022
Prostate-Specific Membrane Antigen Imaging Before and After 177Lu-PSMA-617 Treatment
February 21, 2022
Examining a Neoadjuvant Intravesical Oncolytic Measles Virus in Patients With Urothelial Carcinoma
February 21, 2022
Avelumab Plus Docetaxel Chemotherapy in Patients With Metastatic Urothelial Carcinoma
February 21, 2022
Unique Genomic Profiles in Distant Metastatic Sites in Patients With Renal Cell Carcinoma
February 21, 2022
VISION Trial Follow-Up: Exposure Adjusted Rates of Treatment-Emergent Adverse Events
February 20, 2022
Tumor Landscapes in Urothelial Carcinoma With or Without Squamous Differentiation
February 20, 2022
Pembrolizumab with Lenvatinib or Placebo for Patients with Advanced Urothelial Carcinoma
February 20, 2022
Radical Cystectomy Versus Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer
February 20, 2022
Pembrolizumab Plus Abiraterone Acetate and Prednisone in Metastatic Castration-Resistant Prostate Cancer
February 18, 2022
Pembrolizumab With or Without Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma
February 18, 2022
Load more
Subscribe to RSS